Blinded Placebo-Controlled Clinical Trial
Jump to navigation
Jump to search
A Blinded Placebo-Controlled Clinical Trial is a Placebo-Controlled Clinical Trial that is a Blinded Clinical Trial.
- Context:
- It can range from being a Single-Blinded Placebo-Controlled Clinical Trial to being a Double-Blinded Placebo-Controlled Clinical Trial.
- …
- See: Open-Label Placebo-Controlled Clinical Trail.
References
2021
- (Baden et al., 2021) ⇒ Lindsey R. Baden, Hana M. El Sahly, Brandon Essink, Karen Kotloff, Sharon Frey, Rick Novak, David Diemert et al. (2021). “Efficacy and Safety of the MRNA-1273 SARS-CoV-2 Vaccine.” New England Journal of Medicine, 384(5).
- QUOTE: ... This phase 3 randomized, observer-blinded, placebo-controlled trial was conducted at 99 centers across the United States. Persons at high risk for SARS-CoV-2 infection or its complications were randomly assigned in a 1:1 ratio to receive two intramuscular injections of mRNA-1273 (100 μg) or placebo 28 days apart. ...